## ALLE: Allegion plc - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 -2.0% below STRENGTH zone (4.0-10.0%); PEG 1.81 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.1% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($157.91)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Allegion PLC (NYSE:ALLE) Given Average Recommendation of "Hold" by Analysts**
- Source: MarketBeat | 20251203T064842 | Neutral | Relevance: 100%
- Allegion PLC (NYSE:ALLE) has received an average recommendation of "Hold" from ten analyst firms, with seven issuing "hold" ratings and three issuing "buy" ratings. The average 1-year price target is $176.3750. The company recently reported strong Q3 earnings, exceeding consensus estimates, and declared a quarterly dividend of $0.51 per share.

**2. Korea Investment CORP Acquires 3,100 Shares of Allegion PLC $ALLE**
- Source: MarketBeat | 20251202T111545 | Somewhat-Bullish | Relevance: 100%
- Korea Investment CORP increased its stake in Allegion PLC by 3.6% in Q2 2025, acquiring an additional 3,100 shares. This brings their total holdings to 88,626 shares valued at $12.77 million, representing approximately 0.10% of the company. Other major institutional investors also increased their positions, contributing to institutional ownership of 92.21%.

**3. Russell Investments Group Ltd. Decreases Stock Holdings in Allegion PLC $ALLE**
- Source: MarketBeat | 20251202T110509 | Somewhat-Bullish | Relevance: 100%
- Russell Investments Group Ltd. significantly reduced its stake in Allegion PLC by 75.2% in Q2 2025, selling over 343,000 shares and retaining a smaller holding valued at approximately $16.32 million. Despite this decrease, other institutions like AQR Capital Management and Robeco Institutional Asset Management B.V. notably increased their positions, indicating varied institutional investor sentiment. Allegion PLC reported strong quarterly earnings, beating estimates with $2.30 EPS and $1.07 billion revenue, and maintains a "Hold" consensus analyst rating with a target price of $176.38.

**4. Allegion PLC $ALLE Shares Sold by Distillate Capital Partners LLC**
- Source: MarketBeat | 20251202T095630 | Somewhat-Bullish | Relevance: 100%
- Distillate Capital Partners LLC reduced its stake in Allegion PLC by 10.4% in the second quarter, selling 11,117 shares and retaining 96,274 shares valued at approximately $13.9 million. Other institutional investors increased their holdings, and analyst consensus rates Allegion as "Hold" with an average price target of $176.38, despite some recent upgrades. Allegion recently surpassed earnings and revenue estimates and announced a quarterly dividend of $0.51.

**5. Brady Corporation elects Board of Directors and declares regular dividend to shareholders**
- Source: The Manila Times | 20251203T180849 | Neutral | Relevance: 63%
- Brady Corporation announced that its shareholders unanimously elected director nominees to a one-year term at their annual meeting in Milwaukee. Following this, the Board of Directors declared a dividend of $0.245 per share for Class A Common Stock, payable on January 30, 2026, to shareholders of record by January 9, 2026. The company, an international manufacturer of identification and protection solutions, reported fiscal 2025 sales of approximately $1.51 billion.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 1 ($0.26M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 12.3% (-1.0%)
- Blackrock Inc.: 8.6% (-13.5%)
- Boston Partners: 5.5% (+1.0%)
- Kayne Anderson Rudni: 5.1% (-2.3%)
- State Street Corpora: 4.9% (+6.6%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.81 elevated, pricing in significant growth expectations. Forward P/E 18.4x stretched relative to 9% growth. Quality metrics strong (ROE 36%, ROA 10%, margin 16%). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $13.8B |
| Beta | 1.04 |
| 52W Range | $116.57 - $180.68 |
| Short Interest | 4.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.81 |
| Forward P/E | 18.4 |
| Current P/E | 20.1 |
| YoY Growth | 8.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 0.1% to -2.0% (-2.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 6.0pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.08x) but short-term weakness (below SMA20). MACD histogram positive (0.56), confirming momentum. RSI neutral at 45. OFD pattern: -SUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.97% (CS: 30) | Neutral |
| RSI_14 | 45.2 | Neutral |
| MACD Histogram | 0.56 | Bullish |
| vs SMA20 | 0.999x | Below |
| vs SMA50 | 0.966x | Below |
| vs SMA200 | 1.080x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $164.03
- **Stop Loss:** $157.91 (3.7% risk)
- **Target:** $170.15 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 155
- **Position Value:** $25,424.65
- **Portfolio %:** 25.42%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderately constructive conditions. Fed dovish pivot expectations from weak jobs data and declining VIX suggest improving risk appetite, though narrow breadth at 51% indicates selective participation. Focus on quality sectors benefiting from rate cut expectations.*

### Earnings

**Next:** 2026-02-17 (Est: $1.98)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.24 | $2.30 | +2.5% |
| 2025Q2 | $1.99 | $2.04 | +2.7% |
| 2025Q1 | $1.67 | $1.86 | +11.2% |
| 2024Q4 | $1.75 | $1.86 | +6.3% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*